Abstract: The present application relates to novel compounds comprising a moiety that leads to the metabolic production of ketones bonded to a ketone-potentiated anti-epileptic drug, compositions comprising these compounds, and their use, for example for the treatment of epilepsy, and other CNS diseases, disorders or conditions.
Type:
Application
Filed:
October 31, 2016
Publication date:
February 16, 2017
Applicant:
Ketogen, Inc.
Inventors:
Joseph A. Araujo, John S. Andrews, Subhash C. Annedi, Guy A. Higgins, Norton W. Milgram, Paula J. Estey, Gary L.W.G. Robinson, Jaipal R. Nagireddy
Abstract: The present application relates to novel compounds comprising a moiety that leads to the metabolic production of ketones bonded to a ketone-potentiated anti-epileptic drug, compositions comprising these compounds, and their use, for example for the treatment of epilepsy, and other CNS diseases, disorders or conditions.
Type:
Grant
Filed:
June 2, 2015
Date of Patent:
November 1, 2016
Assignee:
Ketogen Inc.
Inventors:
Joseph A. Araujo, John S. Andrews, Subhash C. Annedi, Guy A. Higgins, Norton W. Milgram, Paula J. Estey, Gary L. W. G. Robinson, Jaipal R. Nagireddy
Abstract: The present application relates to novel compounds comprising a moiety that leads to the metabolic production of ketones bonded to a ketone-potentiated anti-epileptic drug, compositions comprising these compounds, and their use, for example for the treatment of epilepsy, and other CNS diseases, disorders or conditions.
Type:
Application
Filed:
June 2, 2015
Publication date:
December 3, 2015
Applicant:
Ketogen Inc.
Inventors:
Joseph A. Araujo, John S. Andrews, Subhash C. Annedi, Guy A. Higgins, Norton W. Milgram, Paula J. Estey, Gary L.W.G. Robinson, Jaipal R. Nagireddy